Insightec develops non-invasive, incision-free medical devices that use focused ultrasound guided by MRI to treat neurological disorders and certain cancers. Its technology allows physicians to precisely target tissue without surgery, reducing risk and recovery time for patients.
The company works closely with hospitals, researchers, and healthcare providers to advance treatments for conditions such as essential tremor, Parkinson’s disease, uterine fibroids, and metastatic bone pain. Insightec’s solutions sit at the intersection of medical imaging, therapeutic ultrasound, and advanced software.
What Is Insightec and What Does It Do?
Insightec, founded in 1999 by Kobi Vortman and Oded Tamir, is a Tirat Carmel–based medical device company in Israel.
The company develops the Exablate platform, an MRI-guided focused ultrasound system used in neurology and oncology. The platform enables physicians to treat movement disorders and tumors without incisions by focusing sound waves on targeted tissue under real-time MRI guidance.
Insightec employs 144 people as of December 2021 and operates globally through partnerships with leading hospitals and healthcare institutions.
How Much Funding Has Insightec Raised?
1. Series A
- Amount Raised: $15M
- Date: August 2006
- Lead Investors: Elbit Imaging, GE Equity, MediTech Advisors
- Motivation: To support technology development and early clinical validation.
2. Series B
- Amount Raised: $30M
- Date: November 2007
- Lead Investors: GE Equity, Elbit Imaging, MediTech Advisors
- Motivation: To expand R&D and advance commercialization programs.
3. Series B
- Amount Raised: $13.8M
- Date: February 2012
- Lead Investors: GE Healthcare
- Motivation: To continue product development and clinical expansion.
4. Series C
- Amount Raised: $30.9M
- Date: December 2012
- Lead Investors: GE Healthcare
- Motivation: To scale manufacturing and regulatory approvals.
5. Series D
- Amount Raised: $12.5M
- Date: September 2014
- Lead Investors: York Capital Management, GEOC
- Motivation: To enhance platform capabilities and expand clinical trials.
6. Series D
- Amount Raised: $22M
- Date: December 2015
- Motivation: To support market entry and commercial adoption.
7. Series E
- Amount Raised: $150M
- Date: December 2017
- Lead Investors: Koch Disruptive Technologies, GE Healthcare, York Capital Management
- Motivation: To accelerate global commercialization and expand indications.
8. Series F
- Amount Raised: $150M
- Date: March 2020
- Lead Investors: Koch Disruptive Technologies
- Motivation: To scale operations and strengthen clinical partnerships.
9. Series G
- Amount Raised: $150M
- Date: June 2024
- Lead Investors: Fidelity Investments, Baillie Gifford, Ally Bridge Group
- Motivation: To advance neurology applications and expand global market reach.
Total Funding Raised: $574 Million
Current Valuation: $375 Million (as of Jun 2024)
Latest Funding Date: June, 2024
Key Investors
1. Fidelity Investments
- Details: A global asset management firm investing across public and private markets.
- Investment Focus Areas: Healthcare, technology, life sciences, innovation-driven companies.
- Notable Investments: Uber, SpaceX, Databricks, Meesho.
2. Koch Disruptive Technologies
- Details: An investment arm of Koch Industries backing breakthrough, high-impact technologies.
- Investment Focus Areas: Med-tech, industrial innovation, deep technology platforms.
- Notable Investments: Desktop Metal, Vayyar, Zap Energy, Moleaer.
3. GE Healthcare
- Details: A global medical technology and diagnostics leader supporting imaging-driven treatment innovation.
- Investment Focus Areas: Medical devices, imaging platforms, healthcare technology.
- Notable Investments: Pulmonx, HeartFlow, AirStrip.
4. Baillie Gifford
- Details: A long-term global investment firm backing high-growth technology and healthcare companies.
- Investment Focus Areas: Life sciences, AI, healthcare innovation.
- Notable Investments: Moderna, Tempus, Illumina, Wise.
5. York Capital Management
- Details: A global investment firm providing growth capital to emerging and late-stage companies.
- Investment Focus Areas: Healthcare, technology, special situations.
- Notable Investments: Oatly, Moncler, Grubhub.
6. Ally Bridge Group
- Details: A global healthcare-focused investment firm specializing in med-tech and life sciences.
- Investment Focus Areas: Biotechnology, medical devices, health innovation.
- Notable Investments: Imperative Care, Synthego, MedTech Innovator companies.
Where Is Insightec’s Headquarters?
Insightec is headquartered in Tirat Carmel, Israel, a growing hub for advanced medical device innovation and healthcare research.
What’s Next for Insightec?
Insightec is positioned to expand the clinical use of focused ultrasound across additional neurological and oncological indications. With strong backing from global healthcare investors, the company is expected to invest further in clinical trials, regulatory approvals, and hospital partnerships, potentially accelerating adoption of incision-free therapies worldwide.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like Insightec. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.